Bousmah Marwân-Al-Qays, Protopopescu Camelia, Mpoudi-Etame Mireille, Omgba Bassega Pierrette, Maradan Gwenaëlle, Olinga Justin, Varloteaux Marie, Tovar-Sanchez Tamara, Delaporte Éric, Kouanfack Charles, Boyer Sylvie. Improvements in Patient-Reported Outcomes Following Initiation of Dolutegravir-Based or Low-Dose Efavirenz-Based First-Line Antiretroviral Therapy: A Four-Year Longitudinal Analysis in Cameroon (NAMSAL ANRS 12313 Trial). Journal of Acquired Immune Deficiency Syndromes - JAIDS. 2023;94(3):262-272.